120 related articles for article (PubMed ID: 21897294)
41. The effect of atorvastatin on heart rate variability and lipoproteins in patients treated with coronary bypass surgery.
Riahi S; Schmidt EB; Amanavicius N; Karmisholt J; Jensen HS; Christoffersen RP; Niebuhr U; Christensen JH; Toft E
Int J Cardiol; 2006 Aug; 111(3):436-41. PubMed ID: 16290290
[TBL] [Abstract][Full Text] [Related]
42. Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases.
Bianchi S; Bigazzi R; Campese VM
Am J Kidney Dis; 2010 Apr; 55(4):671-81. PubMed ID: 20097461
[TBL] [Abstract][Full Text] [Related]
43. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
44. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
45. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
46. Effects of atorvastatin on arterial stiffness in chronic kidney disease: a randomised controlled trial.
Fassett RG; Robertson IK; Ball MJ; Geraghty DP; Sharman JE; Coombes JS
J Atheroscler Thromb; 2010 Mar; 17(3):235-41. PubMed ID: 20032570
[TBL] [Abstract][Full Text] [Related]
47. Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial.
Holme I; Fayyad R; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Holdaas H; Pedersen TR;
J Intern Med; 2010 Jun; 267(6):567-75. PubMed ID: 20141566
[TBL] [Abstract][Full Text] [Related]
48. Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects.
Heusser K; Tank J; Diedrich A; Engeli S; Klaua S; Krüger N; Strauss A; Stoffels G; Luft FC; Jordan J
Clin Pharmacol Ther; 2006 May; 79(5):500-8. PubMed ID: 16678551
[TBL] [Abstract][Full Text] [Related]
49. Atorvastatin improves the impaired baroreflex sensitivity via anti-oxidant effect in the rostral ventrolateral medulla of SHRSP.
Kishi T; Hirooka Y; Konno S; Sunagawa K
Clin Exp Hypertens; 2009 Nov; 31(8):698-704. PubMed ID: 20001462
[TBL] [Abstract][Full Text] [Related]
50. Peripheral chemosensor function is blunted in moderate to severe chronic kidney disease.
Rassaf T; Schueller P; Westenfeld R; Floege J; Eickholt C; Hennersdorf M; Merx MW; Schauerte P; Kelm M; Meyer C
Int J Cardiol; 2012 Mar; 155(2):201-5. PubMed ID: 20980069
[TBL] [Abstract][Full Text] [Related]
51. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
Taneva E; Borucki K; Wiens L; Makarova R; Schmidt-Lucke C; Luley C; Westphal S
Am J Cardiol; 2006 Apr; 97(7):1002-6. PubMed ID: 16563905
[TBL] [Abstract][Full Text] [Related]
52. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
53. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
54. Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients.
Bayés B; Granada ML; Lauzurica R; Pastor MC; Navarro M; Bonet J; Llopis MA; Romero R
Transplant Proc; 2005 Nov; 37(9):3808-12. PubMed ID: 16386546
[TBL] [Abstract][Full Text] [Related]
55. Effect of atorvastatin on CYP2C9 metabolic activity as measured by the formation rate of losartan metabolite in hypercholesterolaemic patients.
Yasar U; Sain-Guven G; Yardimci Y; Kilicarslan A; Babaoglu MO; Bozkurt A
Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):73-7. PubMed ID: 21332946
[TBL] [Abstract][Full Text] [Related]
56. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
Sever PS; Poulter NR; Dahlof B; Wedel H;
J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
[TBL] [Abstract][Full Text] [Related]
57. Chronic renin inhibition lowers blood pressure and reduces upright muscle sympathetic nerve activity in hypertensive seniors.
Okada Y; Jarvis SS; Best SA; Bivens TB; Adams-Huet B; Levine BD; Fu Q
J Physiol; 2013 Dec; 591(23):5913-22. PubMed ID: 24060993
[TBL] [Abstract][Full Text] [Related]
58. Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation.
Lai WT; Lee KT; Chu CS; Voon WC; Yen HW; Tsai LY; Sheu SH
Int J Cardiol; 2005 Feb; 98(3):459-64. PubMed ID: 15708180
[TBL] [Abstract][Full Text] [Related]
59. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
Fonseca FA; Ruiz A; Cardona-Muñoz EG; Silva JM; Fuenmayor N; Marotti M;
Curr Med Res Opin; 2005 Aug; 21(8):1307-15. PubMed ID: 16083541
[TBL] [Abstract][Full Text] [Related]
60. HMG CoA reductase inhibition and endothelial function in children with chronic kidney disease (CKD)--a pilot study.
Mackie FE; Rosenberg AR; Harmer JA; Kainer G; Celermajer DS
Acta Paediatr; 2010 Mar; 99(3):457-9. PubMed ID: 20050832
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
